1
关注
922
浏览

基于风险的电子数据审查是否可以接受?

您还未登录!暂时最多只可查看 1 条回答

登录! 还没有账号?去注册

trer234 一阶会员 用户来自于: 广东省深圳市
2023-10-26 22:45

 Yes. The principles of quality risk management may be applied during the review of electronic data and review by exception is permitted, when scientifically justified.

是的,质量风险管理的原则可以在审查电子数据的过程中应用,在有科学依据的情况下,允许例外审查。

Exception Reporting is used commonly as a tool to focus the review of electronic data such as (but not limited to) electronic batch records. Exception reporting rapidly highlights to the reviewer one of the most critical elements of batch review, i.e. the exceptions. The level of review of the full electronic batch record can vary based on the exceptions as well as the level of confidence and experience with a particular process. Appropriate testing and validation must be completed for the automated system and the output Batch Exception Report to ensure its functionality meets the business and regulatory requirements as per GMP.

异常报告通常被用作重点审查电子数据的工具,如(但不限于)电子批次记录。异常报告能迅速向审查者强调批次审查中最关键的因素之一,即异常情况。对完整的电子批次记录的审查水平可以根据例外情况以及对某一特定过程的信心和经验水平而有所不同。必须对自动化系统和输出的批次异常报告完成适当的测试和验证,以确保其功能符合GMP规定的业务和监管要求。


关于作者

问题动态

发布时间
2023-10-26 22:45
更新时间
2023-10-26 22:45
关注人数
1 人关注

推荐内容

How does FDA use the term “backup” in § 211.68(b)?
How does FDA recommend data integrity problems be addressed?
对与数据完整性有关的自检计划有什么期望?
How should access to CGMP computer systems be restricted?
What is “data integrity”?
对于外包给其他公司的GMP活动,我公司在数据完整性方面有什么责任?
公司应如何设计和控制他们的纸质文件系统,以防止未经授权的GMP数据的重新出现?
What is “metadata”?
Can I use electronic signature instead of handwritten signature?
hy has FDA cited use of actual samples during “system suitability”?